Comments
Long-term investors can buy the shares of Aurobindo Pharma (₹565.80). The recent rally signals that downtrend that was in place since May 2021 could have found a bottom. A short-term correction to ₹520-510 from current levels cannot be ruled out. An eventual break above ₹580 can target ₹750-800 possibly in the first half of next year. A multiyear price analysis indicate that Aurobindo Pharma share price has potential to target ₹1,100-1,200 over the next couple of years. Buy now and accumulate at ₹520. Keep the stop-loss at ₹370. Revise it up to ₹650 as soon as the stock rallies to ₹790. Move the stop-loss further up to ₹780 when the stock touches ₹930. Book profits at ₹1,000.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.